• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一名接受依鲁替尼治疗慢性淋巴细胞白血病的患者发生了颅骨曲霉病。

Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia.

作者信息

Beresford Rohan, Dolot Virginia, Foo Hong

机构信息

Department of Microbiology and Infectious Diseases, NSW Health Pathology-South West Sydney, Sydney, Australia.

School of Medicine, Western Sydney University, Campbelltown, Australia.

出版信息

Med Mycol Case Rep. 2019 Feb 28;24:27-29. doi: 10.1016/j.mmcr.2019.02.005. eCollection 2019 Jun.

DOI:10.1016/j.mmcr.2019.02.005
PMID:30899641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6409380/
Abstract

Cerebral abscess due to is a relatively uncommon presentation, even amongst immunocompromised patients. However it is increasingly being recognized as a complication of ibrutinib therapy in patients with chronic lymphocytic leukemia. We present a case of cerebral abscesses caused by in a patient receiving ibrutinib for chronic lymphocytic leukemia.

摘要

由……引起的脑脓肿是一种相对不常见的表现，即使在免疫功能低下的患者中也是如此。然而，它越来越被认为是慢性淋巴细胞白血病患者接受依鲁替尼治疗的一种并发症。我们报告一例接受依鲁替尼治疗慢性淋巴细胞白血病的患者发生由……引起的脑脓肿的病例。

注

原文中“due to”和“caused by”后缺少具体病因，翻译时保留了省略部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4eb/6409380/0bdde8b31022/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4eb/6409380/90884054c90b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4eb/6409380/0bdde8b31022/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4eb/6409380/90884054c90b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4eb/6409380/0bdde8b31022/gr2.jpg

相似文献

1
Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia.一名接受依鲁替尼治疗慢性淋巴细胞白血病的患者发生了颅骨曲霉病。
Med Mycol Case Rep. 2019 Feb 28;24:27-29. doi: 10.1016/j.mmcr.2019.02.005. eCollection 2019 Jun.
2
Cerebral aspergillosis in a patient on ibrutinib therapy-A predisposition not to overlook.接受依鲁替尼治疗的患者发生脑曲霉病——一种不容忽视的易患因素。
J Oncol Pharm Pract. 2019 Sep;25(6):1486-1490. doi: 10.1177/1078155218788717. Epub 2018 Jul 25.
3
Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia.与依鲁替尼治疗慢性淋巴细胞白血病相关的侵袭性曲霉病
Respir Med Case Rep. 2017 Mar 20;21:27-29. doi: 10.1016/j.rmcr.2017.03.011. eCollection 2017.
4
A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy.一名接受一线伊布替尼治疗的慢性淋巴细胞白血病患者发生中枢神经系统曲霉菌病的病例。
Med Mycol Case Rep. 2019 Dec 5;27:17-21. doi: 10.1016/j.mmcr.2019.12.007. eCollection 2020 Mar.
5
Cerebral aspergillosis and facial acneiform lesions following initiation of ibrutinib in a patient with chronic lymphocytic leukemia.一名慢性淋巴细胞白血病患者在开始使用依鲁替尼后出现脑曲霉病和面部痤疮样病变。
IDCases. 2021 Sep 1;26:e01263. doi: 10.1016/j.idcr.2021.e01263. eCollection 2021.
6
Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.伊布替尼相关侵袭性真菌病在慢性淋巴细胞白血病和非霍奇金淋巴瘤患者中的观察性研究。
Mycoses. 2019 Dec;62(12):1140-1147. doi: 10.1111/myc.13001. Epub 2019 Oct 22.
7
Cerebral Invasive Aspergillosis in a Case of Chronic Lymphocytic Leukemia with Bruton Tyrosine Kinase Inhibitor.慢性淋巴细胞白血病伴布鲁顿酪氨酸激酶抑制剂患者的侵袭性脑曲霉病。
Curr Oncol. 2021 Feb 8;28(1):837-841. doi: 10.3390/curroncol28010081.
8
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib.伊布替尼治疗患者的早发性侵袭性曲霉菌病和其他真菌感染。
Blood. 2018 Apr 26;131(17):1955-1959. doi: 10.1182/blood-2017-11-818286. Epub 2018 Feb 1.
9
A Rare Instance of Simultaneous Infection with Disseminated Nocardia and Pulmonary Aspergillus in a Patient Receiving Treatment with Ibrutinib for Chronic Lymphocytic Leukemia.1例接受伊布替尼治疗慢性淋巴细胞白血病患者同时发生播散性诺卡菌和肺曲霉菌感染的罕见病例
Cureus. 2018 Oct 8;10(10):e3427. doi: 10.7759/cureus.3427.
10
Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?脑曲霉病：接受依鲁替尼治疗慢性淋巴细胞白血病的患者中一种新出现的机会性感染？
Med Mal Infect. 2018 Jun;48(4):294-297. doi: 10.1016/j.medmal.2018.01.003. Epub 2018 Feb 3.

引用本文的文献

1
Case report: a fatal case of infection in an immunocompetent host.病例报告：一例免疫功能正常宿主发生感染的致死病例。
Access Microbiol. 2022 Nov 21;4(11):acmi000453. doi: 10.1099/acmi.0.000453. eCollection 2022.
2
A Systematic Review to Assess the Relationship between Disseminated Cerebral Aspergillosis, Leukemias and Lymphomas, and Their Respective Therapeutics.一项评估播散性脑曲霉病、白血病和淋巴瘤及其各自治疗方法之间关系的系统评价。
J Fungi (Basel). 2022 Jul 11;8(7):722. doi: 10.3390/jof8070722.
3
Complete clinical response to combined antifungal therapy in two cats with invasive fungal rhinosinusitis caused by cryptic species in section .

本文引用的文献

1
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib.伊布替尼治疗患者的早发性侵袭性曲霉菌病和其他真菌感染。
Blood. 2018 Apr 26;131(17):1955-1959. doi: 10.1182/blood-2017-11-818286. Epub 2018 Feb 1.
2
Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.行动呼吁：伊布替尼和其他靶向免疫信号通路的小分子激酶抑制剂相关的侵袭性真菌感染。
Clin Infect Dis. 2018 Jan 6;66(1):140-148. doi: 10.1093/cid/cix687.
3
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.
两例由隐球菌属隐匿种引起侵袭性真菌性鼻鼻窦炎的猫对联合抗真菌治疗产生完全临床反应
Med Mycol Case Rep. 2021 Sep 2;34:13-17. doi: 10.1016/j.mmcr.2021.08.005. eCollection 2021 Dec.
4
Cerebral aspergillosis and facial acneiform lesions following initiation of ibrutinib in a patient with chronic lymphocytic leukemia.一名慢性淋巴细胞白血病患者在开始使用依鲁替尼后出现脑曲霉病和面部痤疮样病变。
IDCases. 2021 Sep 1;26:e01263. doi: 10.1016/j.idcr.2021.e01263. eCollection 2021.
5
Disseminated invasive aspergillosis caused by Aspergillus felis in a cat.猫体内感染的黄曲霉所致播散性侵袭性曲霉病。
J Vet Intern Med. 2021 Sep;35(5):2395-2400. doi: 10.1111/jvim.16245. Epub 2021 Aug 20.
6
Aspergillosis of central nervous system in patients with leukemia and stem cell transplantation: a systematic review of case reports.白血病和干细胞移植患者中枢神经系统曲霉病：病例报告的系统评价。
Ann Clin Microbiol Antimicrob. 2021 Jun 15;20(1):44. doi: 10.1186/s12941-021-00452-9.
7
A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy.一名接受一线伊布替尼治疗的慢性淋巴细胞白血病患者发生中枢神经系统曲霉菌病的病例。
Med Mycol Case Rep. 2019 Dec 5;27:17-21. doi: 10.1016/j.mmcr.2019.12.007. eCollection 2020 Mar.
8
Fungal Infections with Ibrutinib and Other Small-Molecule Kinase Inhibitors.依鲁替尼及其他小分子激酶抑制剂引发的真菌感染
Curr Fungal Infect Rep. 2019 Sep;13(3):86-98. doi: 10.1007/s12281-019-00343-9. Epub 2019 Jul 5.
依鲁替尼对原发性中枢神经系统淋巴瘤中B细胞受体信号传导的抑制作用
Cancer Cell. 2017 Jun 12;31(6):833-843.e5. doi: 10.1016/j.ccell.2017.04.012. Epub 2017 May 25.
4
Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib.依鲁替尼治疗的慢性淋巴细胞恶性肿瘤患者中合并脑受累的播散性隐球菌病
Open Forum Infect Dis. 2017 Feb 9;4(1):ofw261. doi: 10.1093/ofid/ofw261. eCollection 2017 Winter.
5
Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia.与依鲁替尼治疗慢性淋巴细胞白血病相关的侵袭性曲霉病
Respir Med Case Rep. 2017 Mar 20;21:27-29. doi: 10.1016/j.rmcr.2017.03.011. eCollection 2017.
6
Ibrutinib for Chronic Lymphocytic Leukemia.伊布替尼用于治疗慢性淋巴细胞白血病。
N Engl J Med. 2016 Apr 21;374(16):1593-4. doi: 10.1056/NEJMc1600328.
7
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.《2014年血液系统恶性肿瘤和造血干细胞移植抗真菌预防的共识指南》
Intern Med J. 2014 Dec;44(12b):1283-97. doi: 10.1111/imj.12595.
8
Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs.新型费氏枝孢菌，一种在人类、猫和狗中引发侵袭性曲霉病的新兴病原体。
PLoS One. 2013 Jun 14;8(6):e64871. doi: 10.1371/journal.pone.0064871. Print 2013.
9
Invasive aspergillosis.侵袭性曲霉病
Clin Infect Dis. 1998 Apr;26(4):781-803; quiz 804-5. doi: 10.1086/513943.